Read + Share
Li M, Kirtane AR, Kiyokawa J, Nagashima H, et al. Local Targeting of NAD(+) Salvage Pathway Alters the Immune Tumor
Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma. Cancer Res 2021;81:1922.
PMID: 34003791
|
 |
|
Li M, Kirtane AR, Kiyokawa J, Nagashima H, et al. Local Targeting of NAD(+) Salvage Pathway Alters the Immune Tumor
Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma. Cancer Res 2021;81:1922.
PMID: 34003791
|
|
|
|